Intracellular expression of single chain antibodies reverts ErbB-2 transformation

作者: R.R. Beerli , W. Wels , N.E. Hynes

DOI: 10.1016/S0021-9258(19)51027-4

关键词: Endoplasmic reticulumErbBPeptide sequenceBiologyMolecular biologyReceptorMonoclonal antibodyImmunoglobulin light chainReceptor tyrosine kinaseSingle-Chain Antibodies

摘要: We report a novel approach for specific in vivo inactivation of the ErbB-2 receptor tyrosine kinase and suppression ErbB-2-induced transformation. Genes encoding single chain antibodies that specifically bind to extracellular domain human were constructed expressed intracellularly NIH/3T3 fibroblasts transformed by activated ErbB-2. The are derived from monoclonal FRP5 FWP51 (Harwerth, I.M., Wels, W., Marte, B. M., Hynes, N. E. (1992) J. Biol. Chem. 267, 15160-15167) composed heavy light variable domains connected flexible peptide linker. provided with: 1) an N-terminal hydrophobic leader sequence target their synthesis lumen endoplasmic reticulum, 2) C-terminal retention signal prevent secretion. When ErbB-2-transformed cells, bound prevented its transit through reticulum. This resulted functional reversion phenotype. is first demonstration targeted stable cellular oncoprotein via intracellular antibody expression. use such strategy represents simple powerful study function receptors other proteins.

参考文章(41)
Ina-Maria Harwerth, Nancy E. Hynes, Bernd Groner, Marcel Mueller, Winfried Wels, Selective Inhibition of Tumor Cell Growth by a Recombinant Single-Chain Antibody-Toxin Specific for the erbB-2 Receptor Cancer Research. ,vol. 52, pp. 6310- 6317 ,(1992)
S S Huang, H A Koh, Y Konish, L D Bullock, J S Huang, Differential processing and turnover of the oncogenically activated neu/erb B2 gene product and its normal cellular counterpart. Journal of Biological Chemistry. ,vol. 265, pp. 3340- 3346 ,(1990) , 10.1016/S0021-9258(19)39772-8
I.M. Harwerth, W Wels, B.M. Marte, N.E. Hynes, Monoclonal antibodies against the extracellular domain of the erbB-2 receptor function as partial ligand agonists Journal of Biological Chemistry. ,vol. 267, pp. 15160- 15167 ,(1992) , 10.1016/S0021-9258(18)42160-6
O Segatto, C R King, J H Pierce, P P Di Fiore, S A Aaronson, Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene. Molecular and Cellular Biology. ,vol. 8, pp. 5570- 5574 ,(1988) , 10.1128/MCB.8.12.5570
Teresa C. Dugger, Carlos L. Arteaga, Elaina Mann, Susan S. Elliger, Laura K. Shawver, Ligand-like effects induced by anti-c-erbB-2 antibodies do not correlate with and are not required for growth inhibition of human carcinoma cells. Cancer Research. ,vol. 54, pp. 1367- 1373 ,(1994)
R M Hudziak, G D Lewis, M Winget, B M Fendly, H M Shepard, A Ullrich, p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Molecular and Cellular Biology. ,vol. 9, pp. 1165- 1172 ,(1989) , 10.1128/MCB.9.3.1165
J. Richner, H.A. Gerber, G.W. Locher, A. Goldhirsch, R.D. Gelber, W.J. Gullick, M.S. Berger, B. Groner, N.E. Hynes, c-erbB-2 protein expression in node negative breast cancer Annals of Oncology. ,vol. 1, pp. 263- 268 ,(1990) , 10.1093/OXFORDJOURNALS.ANNONC.A057745
Michael J. Lewis, Hugh R. B. Pelham, A human homologue of the yeast HDEL receptor. Nature. ,vol. 348, pp. 162- 163 ,(1990) , 10.1038/348162A0